| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20,500 | 14 Jun 2023 | Direct | ||
| Black Diamond Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16,500 | 16 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:27 |
| BDTX | Black Diamond Therapeutics, Inc. | 16 May 2023 | 1 | $0 | 4 | Director | 17 May 2023, 21:11 |
| GLUE | Monte Rosa Therapeutics, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 16:30 |
| BDTX | Black Diamond Therapeutics, Inc. | 10 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 19:09 |
| GLUE | Monte Rosa Therapeutics, Inc. | 23 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 17:00 |
| GLUE | Monte Rosa Therapeutics, Inc. | 23 Jun 2021 | 0 | $0 | 3 | Director | 23 Jun 2021, 20:55 |
| BDTX | Black Diamond Therapeutics, Inc. | 18 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 18:14 |